A Study of Daratumumab With Pomalidomide, Dexamethasone, and All-Transretinoic Acid in Patients With Multiple Myeloma
Clinical trial NCT04700176 · TERMINATED
Trial details
- NCT number
- NCT04700176
- Sponsor
- Hackensack Meridian Health
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-02
- Primary completion
- 2023-11-15
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.